Sg Americas Securities, LLC Altimmune, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 34,436 shares of ALT stock, worth $236,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,436

Previous 254,571 86.47%

Holding current value

$236,230

Previous $1.69 Million 87.54%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$5.5 - $8.1 $1.21 Million - $1.78 Million	-220,135 Reduced 86.47%	34,436 $211,000
Q2 2024 Jul 12, 2024	BUY	$5.91 - $10.23 $1.27 Million - $2.2 Million	214,968 Added 542.81%	254,571 $1.69 Million
Q1 2024 May 06, 2024	BUY	$8.22 - $13.81 $132,161 - $222,037	16,078 Added 68.34%	39,603 $403,000
Q4 2023 Jan 12, 2024	SELL	$2.14 - $11.62 $41,860 - $227,298	-19,561 Reduced 45.4%	23,525 $265,000
Q3 2023 Oct 13, 2023	BUY	$2.4 - $3.45 $39,986 - $57,480	16,661 Added 63.05%	43,086 $112,000
Q2 2023 Jul 10, 2023	BUY	$3.45 - $5.97 $38,719 - $67,001	11,223 Added 73.83%	26,425 $93,000
Q1 2023 Apr 28, 2023	SELL	$4.19 - $16.83 $36,222 - $145,495	-8,645 Reduced 36.25%	15,202 $64,000
Q4 2022 Feb 02, 2023	BUY	$8.74 - $16.45 $85,520 - $160,963	9,785 Added 69.58%	23,847 $392,000
Q3 2022 Oct 31, 2022	BUY	$10.67 - $22.41 $6,135 - $12,885	575 Added 4.26%	14,062 $180,000
Q2 2022 Jul 29, 2022	BUY	$3.94 - $11.77 $53,138 - $158,741	13,487 New	13,487 $158,000
Q1 2022 Apr 29, 2022	SELL	$5.9 - $9.45 $80,033 - $128,189	-13,565 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$8.69 - $12.48 $116,585 - $167,431	-13,416 Reduced 49.72%	13,565 $124,000
Q3 2021 Nov 01, 2021	BUY	$8.43 - $16.81 $227,449 - $453,550	26,981 New	26,981 $305,000
Q2 2021 Aug 12, 2021	SELL	$9.85 - $16.46 $108,034 - $180,533	-10,968 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$12.71 - $24.31 $15,976 - $30,557	1,257 Added 12.94%	10,968 $155,000
Q4 2020 Feb 04, 2021	BUY	$7.84 - $14.22 $76,134 - $138,090	9,711 New	9,711 $110,000
Q4 2019 Jan 28, 2020	SELL	$1.53 - $2.15 $19,940 - $28,020	-13,033 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$1.95 - $2.66 $25,414 - $34,667	13,033 New	13,033 $25,000

Others Institutions Holding ALT

# of Institutions

190

Shares Held

42.2M

Call Options Held

1.05M

Put Options Held

582K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $336M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Altimmune, Inc. Transaction History